Skip to main content

Intensive Care of the Deceased Multiorgan Donor: One Donor, Nine Lives

  • Chapter
  • First Online:

Abstract

Transplantation is a life-saving therapy for patients with end-stage organ failure. Donor management is central to expanding the organ pool in an era where demand outstrips supply of organs. One critical challenge to donor management includes the profound pathophysiologic changes that occur during and following brain death that can threaten the viability and suitability of a particular organ for transplant. Meticulous donor management can help minimize organ damage and help transform marginal organs suitable for retrieval and transplantation.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Mascia L, Pasero D, Slutsky AS, Arguis MJ, Berardino M, Grasso S, et al. Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: a randomized controlled trial. JAMA. 2010;304(23):2620–7.

    Article  CAS  PubMed  Google Scholar 

  2. Singbartl K, Murugan R, Kaynar AM, Crippen DW, Tisherman SA, Shutterly K, et al. Intensivist-led management of brain-dead donors is associated with an increase in organ recovery for transplantation. Am J Transplant. 2011;11(7):1517–21.

    Article  CAS  PubMed  Google Scholar 

  3. Chen EP, Bittner HB, Kendall SW, Van Trigt P. Hormonal and hemodynamic changes in a validated animal model of brain death. Crit Care Med. 1996;24(8):1352–9.

    Article  CAS  PubMed  Google Scholar 

  4. Powner DJ, Hendrich A, Nyhuis A, Strate R. Changes in serum catecholamine levels in patients who are brain dead. J Heart Lung Transplant. 1992;11(6):1046–53.

    CAS  PubMed  Google Scholar 

  5. Baroldi G, Di Pasquale G, Silver MD, Pinelli G, Lusa AM, Fineschi V. Type and extent of myocardial injury related to brain damage and its significance in heart transplantation: a morphometric study. J Heart Lung Transplant. 1997;16(10):994–1000.

    CAS  PubMed  Google Scholar 

  6. Yeh Jr T, Wechsler AS, Graham LJ, Loesser KE, Sica DA, Wolfe L, et al. Acute brain death alters left ventricular myocardial gene expression. J Thorac Cardiovasc Surg. 1999;117(2):365–74.

    Article  PubMed  Google Scholar 

  7. van Der Hoeven JA, Ter Horst GJ, Molema G, de Vos P, Girbes AR, Postema F, et al. Effects of brain death and hemodynamic status on function and immunologic activation of the potential donor liver in the rat. Ann Surg. 2000;232(6):804–13.

    Article  PubMed Central  Google Scholar 

  8. van der Hoeven JG, Olsman J. Hemodynamic monitoring in the critically ill patient. Neth J Med. 2000;57(3):71–3.

    Article  PubMed  Google Scholar 

  9. Kusaka M, Pratschke J, Wilhelm MJ, Ziai F, Zandi-Nejad K, Mackenzie HS, et al. Activation of inflammatory mediators in rat renal isografts by donor brain death. Transplantation. 2000;69(3): 405–10.

    Article  CAS  PubMed  Google Scholar 

  10. Murugan R, Venkataraman R, Wahed AS, Elder M, Hergenroeder G, Carter M, et al. Increased plasma interleukin-6 in donors is associated with lower recipient hospital-free survival after cadaveric organ transplantation. Crit Care Med. 2008;36(6):1810–6.

    Article  CAS  PubMed  Google Scholar 

  11. Lu J, Goh SJ, Tng PY, Deng YY, Ling EA, Moochhala S. Systemic inflammatory response following acute traumatic brain injury. Front Biosci (Landmark Ed). 2009;14:3795–813.

    Article  CAS  Google Scholar 

  12. Mertes PM, Burtin P, Carteaux JP, Pinelli G, Jaboin Y, Burlet C, et al. Changes in hemodynamic performance and oxygen consumption during brain death in the pig. Transplant Proc. 1994;26(1):229–30.

    CAS  PubMed  Google Scholar 

  13. Novitzky D, Horak A, Cooper DK, Rose AG. Electrocardiographic and histopathologic changes developing during experimental brain death in the baboon. Transplant Proc. 1989;21(1 Pt 3):2567–9.

    CAS  PubMed  Google Scholar 

  14. Roelsgaard K, Botker HE, Stodkilde-Jorgensen H, Andreasen F, Jensen SL, Keiding S. Effects of brain death and glucose infusion on hepatic glycogen and blood hormones in the pig. Hepatology. 1996;24(4):871–5.

    Article  CAS  PubMed  Google Scholar 

  15. Powner DJ, Hendrich A, Lagler RG, Ng RH, Madden RL. Hormonal changes in brain dead patients. Crit Care Med. 1990;18(7):702–8.

    Article  CAS  PubMed  Google Scholar 

  16. Howlett TA, Keogh AM, Perry L, Touzel R, Rees LH. Anterior and posterior pituitary function in brain-stem-dead donors. A possible role for hormonal replacement therapy. Transplantation. 1989;47(5): 828–34.

    Article  CAS  PubMed  Google Scholar 

  17. Lopau K, Mark J, Schramm L, Heidbreder E, Wanner C. Hormonal changes in brain death and immune activation in the donor. Transpl Int. 2000;13 Suppl 1:S282–5.

    Article  PubMed  Google Scholar 

  18. Barklin A. Systemic inflammation in the brain-dead organ donor. Acta Anaesthesiol Scand. 2009;53(4):425–35.

    Article  CAS  PubMed  Google Scholar 

  19. Chatterjee SN, Terasaki PI, Fine S, Schulman B, Smith R, Fine RN. Pretreatment of cadaver donors with methylprednisolone in human renal allografts. Surg Gynecol Obstet. 1977;145(5):729–32.

    CAS  PubMed  Google Scholar 

  20. Kotsch K, Ulrich F, Reutzel-Selke A, Pascher A, Faber W, Warnick P, et al. Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation: a prospective randomized controlled trial. Ann Surg. 2008;248(6):1042–50.

    Article  PubMed  Google Scholar 

  21. Venkateswaran RV, Patchell VB, Wilson IC, Mascaro JG, Thompson RD, Quinn DW, et al. Early donor management increases the retrieval rate of lungs for transplantation. Ann Thorac Surg. 2008;85(1):278–86. discussion 86.

    Article  PubMed  Google Scholar 

  22. Kuecuek O, Mantouvalou L, Klemz R, Kotsch K, Volk HD, Jonas S, et al. Significant reduction of proinflammatory cytokines by treatment of the brain-dead donor. Transplant Proc. 2005;37(1): 387–8.

    Article  CAS  PubMed  Google Scholar 

  23. Follette DM, Rudich SM, Babcock WD. Improved oxygenation and increased lung donor recovery with high-dose steroid administration after brain death. J Heart Lung Transplant. 1998;17(4): 423–9.

    CAS  PubMed  Google Scholar 

  24. Wood KE, Becker BN, McCartney JG, D'Alessandro AM, Coursin DB. Care of the potential organ donor. N Engl J Med. 2004;351(26):2730–9.

    Article  CAS  PubMed  Google Scholar 

  25. Hefty TR, Cotterell LW, Fraser SC, Goodnight SH, Hatch TR. Disseminated intravascular coagulation in cadaveric organ donors. Incidence and effect on renal transplantation. Transplantation. 1993;55(2):442–3.

    Article  CAS  PubMed  Google Scholar 

  26. Shemie SD, Ross H, Pagliarello J, Baker AJ, Greig PD, Brand T, et al. Organ donor management in Canada: recommendations of the forum on medical management to optimize donor organ potential. CMAJ. 2006;174(6):S13–32.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Mascia L, Mastromauro I, Viberti S, Vincenzi M, Zanello M. Management to optimize organ procurement in brain dead donors. Minerva Anestesiol. 2009;75(3):125–33.

    CAS  PubMed  Google Scholar 

  28. Rosengard BR, Feng S, Alfrey EJ, Zaroff JG, Emond JC, Henry ML, et al. Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donor. Am J Transplant. 2002;2(8):701–11.

    Article  PubMed  Google Scholar 

  29. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41(2):580–637.

    Article  PubMed  Google Scholar 

  30. Murugan R, Venkataraman R, Wahed AS, Elder M, Carter M, Madden NJ, et al. Preload responsiveness is associated with increased interleukin-6 and lower organ yield from brain-dead donors. Crit Care Med. 2009;37(8):2387–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Harvey S, Harrison DA, Singer M, Ashcroft J, Jones CM, Elbourne D, et al. Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): a randomised controlled trial. Lancet. 2005;366(9484): 472–7.

    Article  PubMed  Google Scholar 

  32. Greenberg SB, Murphy GS, Vender JS. Current use of the pulmonary artery catheter. Curr Opin Crit Care. 2009;15(3):249–53.

    Article  PubMed  Google Scholar 

  33. Al-Khafaji A, Murugan R, Wahed AS, Lebovitz DJ, Souter MJ, Kellum JA. Monitoring organ donors to improve transplantation results (MOnIToR) trial methodology. Crit Care Resusc. 2013;15(3):234–40.

    PubMed  PubMed Central  Google Scholar 

  34. Zaroff JG, Rosengard BR, Armstrong WF, Babcock WD, D'Alessandro A, Dec GW, et al. Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations, March 28–29, 2001, Crystal City, VA. Circulation. 2002;106(7):836–41.

    Article  PubMed  Google Scholar 

  35. Hebert PC. Transfusion requirements in critical care (TRICC): a multicentre, randomized, controlled clinical study. Transfusion Requirements in Critical Care Investigators and the Canadian Critical care Trials Group. Br J Anaesth. 1998;81 Suppl 1:25–33.

    PubMed  Google Scholar 

  36. Hebert PC, Wells G, Tweeddale M, Martin C, Marshall J, Pham B, et al. Does transfusion practice affect mortality in critically ill patients? Transfusion Requirements in Critical Care (TRICC) Investigators and the Canadian Critical Care Trials Group. Am J Respir Crit Care Med. 1997;155(5):1618–23.

    Article  CAS  PubMed  Google Scholar 

  37. Zarychanski R, Abou-Setta AM, Turgeon AF, Houston BL, McIntyre L, Marshall JC, et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. JAMA. 2013;309(7):678–88.

    Article  CAS  PubMed  Google Scholar 

  38. Cittanova ML, Leblanc I, Legendre C, Mouquet C, Riou B, Coriat P. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet. 1996; 348(9042):1620–2.

    Article  CAS  PubMed  Google Scholar 

  39. Randell T, Orko R, Hockerstedt K. Peroperative fluid management of the brain-dead multiorgan donor. Acta Anaesthesiol Scand. 1990;34(7):592–5.

    Article  CAS  PubMed  Google Scholar 

  40. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39(2):165–228.

    Article  CAS  PubMed  Google Scholar 

  41. De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362(9):779–89.

    Article  PubMed  Google Scholar 

  42. Schnuelle P, Gottmann U, Hoeger S, Boesebeck D, Lauchart W, Weiss C, et al. Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial. JAMA. 2009;302(10):1067–75.

    Article  CAS  PubMed  Google Scholar 

  43. Pennefather SH, Bullock RE, Mantle D, Dark JH. Use of low dose arginine vasopressin to support brain-dead organ donors. Transplantation. 1995;59(1):58–62.

    Article  CAS  PubMed  Google Scholar 

  44. Plurad DS, Bricker S, Neville A, Bongard F, Putnam B. Arginine vasopressin significantly increases the rate of successful organ procurement in potential donors. Am J Surg. 2012;204(6):856–60. discussion 60-1.

    Article  CAS  PubMed  Google Scholar 

  45. Kinoshita Y, Yahata K, Yoshioka T, Onishi S, Sugimoto T. Long-term renal preservation after brain death maintained with vasopressin and epinephrine. Transpl Int. 1990;3(1):15–8.

    Article  CAS  PubMed  Google Scholar 

  46. D'Amico TA, Meyers CH, Koutlas TC, Peterseim DS, Sabiston Jr DC, Van Trigt P, et al. Desensitization of myocardial beta-adrenergic receptors and deterioration of left ventricular function after brain death. J Thorac Cardiovasc Surg. 1995;110(3):746–51.

    Article  PubMed  Google Scholar 

  47. Rosendale JD, Kauffman HM, McBride MA, Chabalewski FL, Zaroff JG, Garrity ER, et al. Hormonal resuscitation yields more transplanted hearts, with improved early function. Transplantation. 2003;75(8):1336–41.

    Article  PubMed  Google Scholar 

  48. Reichow B, Volkmar FR, Bloch MH. Systematic review and meta-analysis of pharmacological treatment of the symptoms of attention-deficit/hyperactivity disorder in children with pervasive developmental disorders. J Autism Dev Disord. 2013;43(10): 2435–41.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Dhar R, Cotton C, Coleman J, Brockmeier D, Kappel D, Marklin G, et al. Comparison of high- and low-dose corticosteroid regimens for organ donor management. J Crit Care. 2013;28(1):111.e1–7.

    Article  PubMed  Google Scholar 

  50. Guesde R, Barrou B, Leblanc I, Ourahma S, Goarin JP, Coriat P, et al. Administration of desmopressin in brain-dead donors and renal function in kidney recipients. Lancet. 1998;352(9135): 1178–81.

    Article  CAS  PubMed  Google Scholar 

  51. Macdonald PS, Aneman A, Bhonagiri D, Jones D, O'Callaghan G, Silvester W, et al. A systematic review and meta-analysis of clinical trials of thyroid hormone administration to brain dead potential organ donors. Crit Care Med. 2012;40(5):1635–44.

    Article  CAS  PubMed  Google Scholar 

  52. Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283–97.

    Article  PubMed  Google Scholar 

  53. Nygaard CE, Townsend RN, Diamond DL. Organ donor management and organ outcome: a 6-year review from a Level I trauma center. J Trauma. 1990;30(6):728–32.

    Article  CAS  PubMed  Google Scholar 

  54. Tuttle-Newhall JE, Collins BH, Kuo PC, Schoeder R. Organ donation and treatment of the multi-organ donor. Curr Probl Surg. 2003;40(5):266–310.

    Article  PubMed  Google Scholar 

  55. Minambres E, Rodrigo E, Ballesteros MA, Llorca J, Ruiz JC, Fernandez-Fresnedo G, et al. Impact of restrictive fluid balance focused to increase lung procurement on renal function after kidney transplantation. Nephrol Dial Transplant. 2010;25(7):2352–6.

    Article  PubMed  Google Scholar 

  56. Ware LB, Fang X, Wang Y, Sakuma T, Hall TS, Matthay MA. Selected contribution: mechanisms that may stimulate the resolution of alveolar edema in the transplanted human lung. J Appl Physiol (1985). 2002;93(5):1869–74.

    Article  Google Scholar 

  57. Ware L. A randomized trial of nebulized albuterol to enhance resolution of pulmonary edema in 506 brain dead donors. J Heart Lung Transplant. 2012;31 suppl 4:116.

    Article  Google Scholar 

  58. Franklin GA, Santos AP, Smith JW, Galbraith S, Harbrecht BG, Garrison RN. Optimization of donor management goals yields increased organ use. Am Surg. 2010;76(6):587–94.

    PubMed  Google Scholar 

  59. Cypel M, Yeung JC, Machuca T, Chen M, Singer LG, Yasufuku K, et al. Experience with the first 50 ex vivo lung perfusions in clinical transplantation. J Thorac Cardiovasc Surg. 2012;144(5):1200–6.

    Article  PubMed  Google Scholar 

  60. Mackersie RC, Bronsther OL, Shackford SR. Organ procurement in patients with fatal head injuries. The fate of the potential donor. Ann Surg. 1991;213(2):143–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Yang HY, Lin CY, Tsai YT, Lee CY, Tsai CS. Experience of heart transplantation from hemodynamically unstable brain-dead donors with extracorporeal support. Clin Transplant. 2012;26(5):792–6.

    Article  PubMed  Google Scholar 

  62. Dictus C, Vienenkoetter B, Esmaeilzadeh M, Unterberg A, Ahmadi R. Critical care management of potential organ donors: our current standard. Clin Transplant. 2009;23 Suppl 21:2–9.

    Article  PubMed  Google Scholar 

  63. Figueras J, Busquets J, Grande L, Jaurrieta E, Perez-Ferreiroa J, Mir J, et al. The deleterious effect of donor high plasma sodium and extended preservation in liver transplantation. A multivariate analysis. Transplantation. 1996;61(3):410–3.

    Article  CAS  PubMed  Google Scholar 

  64. Wood KE, Coursin DB. Intensivists and organ donor management. Curr Opin Anaesthesiol. 2007;20(2):97–9.

    Article  PubMed  Google Scholar 

  65. De Boer ML, Hu J, Kalvakolanu DV, Hasday JD, Cross AS. IFN-gamma inhibits lipopolysaccharide-induced interleukin-1 beta in primary murine macrophages via a Stat1-dependent pathway. J Interferon Cytokine Res. 2001;21(7):485–94.

    Article  PubMed  Google Scholar 

  66. De Oliveira NC, Osaki S, Maloney JD, Meyer KC, Kohmoto T, D'Alessandro AM, et al. Lung transplantation with donation after cardiac death donors: long-term follow-up in a single center. J Thorac Cardiovasc Surg. 2010;139(5):1306–15.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Raghavan Murugan M.D., M.S., F.R.C.P. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media New York

About this chapter

Cite this chapter

Munshi, L., Murugan, R. (2017). Intensive Care of the Deceased Multiorgan Donor: One Donor, Nine Lives. In: Subramaniam, K., Sakai, T. (eds) Anesthesia and Perioperative Care for Organ Transplantation. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-6377-5_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-6377-5_5

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-6375-1

  • Online ISBN: 978-1-4939-6377-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics